Come up with a name for your new list and we'll add to it:
Terns Pharmaceuticals raised a round of funding on April 04, 2018. Investors include
Lilly Asia Ventures.
Terns Pharmaceuticals is a global biopharmaceutical company committed to discovering and developing molecularly-targeted, oral, small molecule drugs to treat liver disease and cancer.…